# PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers

> **NCT07144176** · PHASE1 · RECRUITING · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 60 (estimated)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** DWJ1511
- **DRUG:** DWC202501

## Key facts

- **NCT ID:** NCT07144176
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2025-09
- **Final completion:** 2025-09
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07144176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07144176, "PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07144176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*